References
- Chow SC. Controversial Issues in Clinical Trials. New York: Chapman and Hall/CRC Press, Taylor & Francis; 2011.
- Chow SC, Yang LY, and Lu Y. Some controversial issues in clinical trials. Ther Innov Regul Sci. 2011;45:163–174.
- Chow SC, Shao J and Wang H. Sample Size Calculation in Clinical Research. 2nd ed. Taylor and Francis; 2007.
- Cui L, Hung HM, Wang SJ. Modification of sample size in group sequential trials. Biometrics. 1999;55:853–857.
- Karlowski TR, Chalmers TC, Frenkel LD, Kapikian AZ, Lewis TL, Lynch JM. Ascorbic acid for the common cold: a prophylactic and therapeutic trial. JAMA. 1975;231:1038–1042.
- Chow SC, Shao J. Analysis of clinical data with breached blindness. Stat Med. 2004;23:1185–1193.
- Chow SC, Shao J, Hu OY. Assessing sensitivity and similarity in bridging studies. J Biopharm Stat. 2002;12:385–400.
- Chow SC, Shao J. Inference for clinical trials with some protocol amendments. J Biopharm Stat. 2005;15:659–666.
- Chow SC, Chang M, Pong A. Statistical consideration of adaptive methods in clinical development. J Biopharm Stat. 2005;15:575–591.
- Chow SC, Chang M. Adaptive Design Methods in Clinical Trials. 2nd ed. New York: Chapman and Hall/CRC Press, Taylor and Francis; 2011.
- Westfall P, Bretz F. . Multiplicity in clinical trials. In: Chow SC, editor. Encyclopedia of Biopharmaceutical Statistics. 3rd ed. New York: Taylor and Francis; 2010:889–896.
- ICH. ICH Harmonized Triplicate Guideline: Statistical Principles for Clinical Trials E9. Geneva: ICH; 1998.
- EMEA. Reflection Paper on Methodological Issues in Confirmatory Clinical Trials Planned with an Adaptive Design. London: European Medicines Agency; 2007. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003616.pdf.
- EMEA. Points to consider on multiplicity issues in clinical trials. London: The European Agency for the evolution of medicinal products evaluation of medicines for human use; 2002. Available from: http://www.ema.europa.eu/docs/en_EG/document_library/scientific_ guideline/2009/09/wc500003640.pdf
- Marcus R, Peritz E, Gabriel KB. On closed testing procedures with special reference to ordered analysis of variance. Biometrika. 1976;63:655–660.
- Soon G. Editorial: missing data – prevention and analysis. J Biopharm Stat. 2009;19(6):941–944.
- Shao J, Chow SC. Reproducibility probability in clinical trials. Stat Med. 2002;21:1727–1742.
- Chow SC, Shao J. Statistics in Drug Research. New York: Marcel Dekker, Inc.; 2002.